<DOC>
	<DOCNO>NCT01309542</DOCNO>
	<brief_summary>The study evaluate long-term safety Desvenlafaxine Succinate ( DVS ) Slow Release ( SR ) open-label treatment adult outpatient primary diagnosis major depressive disorder ( MDD ) . The study also evaluate long-term response subject receive DVS SR clinical global evaluation , functionality , general well-being , pain , absence depressive symptom ( remission ) .</brief_summary>
	<brief_title>Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Desvenlafaxine Succinate</mesh_term>
	<criteria>Outpatients complete doubleblind therapy phase 3 DVS233 SR shortterm study indication MDD , include schedule evaluation , major protocol violation study event , opinion investigator , would preclude subject 's entry longterm , openlabel study . Sexually active individual participate study must use medically acceptable form contraception trial least 15 day last dose study drug . Clinically important abnormality baseline physical examination , unresolved clinically significant abnormality ECG , laboratory test result , vital sign record previous phase 3 DVS233 SR shortterm study indication MDD . Any exception must discuss grant sponsor . Significant risk suicide base clinical judgment , include common suicidal thought , suicide consider possible solution , even without specific plan intention . Presence clinically important hepatic renal disease medical disease might compromise study detrimental subject ( eg , clinically important cardiac arrhythmia , uncontrolled diabetes , uncontrolled hypertension , seizure disorder , myocardial infarction , neurologic disorder , acute illness , neoplastic disorder ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>major depressive disorder</keyword>
	<keyword>desvenlafaxine</keyword>
	<keyword>antidepressant</keyword>
</DOC>